Topic

Chris Spivey is the editorial director of 

Articles

mRNA may not be a train we necessarily all need to get onboard immediately, but we should know where the central train station is located, and what it connects us to.

mRNA Hauptbahnhof

AstraZeneca inked a deal worth up to $320 million to purchase Neogene Therapeutics, a biotech start-up focused on T-cell receptor therapies.

AstraZeneca Acquires Neogene Therapeutics for $320 Million

Merck will purchase Imago BioSciences, a biotechnology company focused on bone marrow disorders, for approximately $1.35 billion. 

Merck Announces $1.35 Billion Acquisition of Imago BioSciences

The agreement aims to develop integrated technology for large-scale exosome production. 

Sartorius BIA Separations and Exopharm Sign Joint Research Agreement

The collaboration will see the companies develop investigational next-generation bispecific immunotherapies for cancer.

Regeneron and Cytomx Announce $2 Billion Oncology Collaboration

The $286 million investment ability is designed to elevate MillioporeSigma’s ability to conduct biosafety testing and analytical development services.

MilliporeSigma Invests $286 Million in US Drug Safety Testing Capacity

Biotech startup, Cradle, has raised $5.4 million in seed funding with an AI-enabled design platform that allows for the synthetic building of cell factories to produce proteins.

Biotech Startup Raises $5.4M to Develop AI-Designed Protein Machines and Cell Factories

CellVax Therapeutics has selected Theragent, a new CDMO, to manufacture clinical trial material for a new Phase II prostate cancer immunotherapy drug candidate.

CellVax and Theragent Form Manufacturing Pact for Novel Cancer Immunotherapy Drug Candidate

The deal will see Sanofi use Insilico’s AI drug discovery platform to advance up to six new drug development candidates.

Sanofi and Insilico Medicine Ink $1.2 Billion Drug Development Deal

Salipro Biotech has entered into a collaboration and license agreement with Sanofi to advance discovery programs.

BioBusiness